{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"maximal dose of Busulfex® that can be given in a two, three, or four day period with acceptable toxicity to myeloma patients, who either are \\> or = 65 years of age or have renal insufficiency, defined as creatinine \\> 3g/dL or creatinine clearance \\< 30 ml/min","groups":[{"id":"OG000","title":"Busulfex"}],"reportingStatus":"POSTED","timeFrame":"three years","title":"Maximal Dose of Busulfex® Given in a 2, 3, or 4 Day Period With Acceptable Toxicity to Myeloma Patients","type":"PRIMARY"}